132 related articles for article (PubMed ID: 7186645)
1. [The alpha-1-acid glycoprotein (alpha-1-ag) in serum of uremic patients in maintenance hemodialysis].
Docci D; Cenciotti L; Turci F; Salvi G
Quad Sclavo Diagn; 1982 Dec; 18(4):416-21. PubMed ID: 7186645
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [Blood folates in chronic uremic patients in dialysis treatment].
Chelazzi G; Bernasconi G; Gastaldi L; Martegani M; Fachinetti A; Giuliani F
Minerva Med; 1980 Oct; 71(42):3073-86. PubMed ID: 7022266
[TBL] [Abstract][Full Text] [Related]
4. [High levels of carcinoembryonic antigen (CEA) in the serum of uremic patients under hemodialysis treatment].
Docci D; Turci F; Pistocchi E
Quad Sclavo Diagn; 1984 Dec; 20(4):435-9. PubMed ID: 6537552
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
6. [Cardiovascular risk markers in hemodialysis].
Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
[TBL] [Abstract][Full Text] [Related]
7. [Serum ferritin and iron therapy in patients treated with periodic hemodialysis].
Docci D; Cenciotti L; Turci F; Salvi G; Mosconi G; Baldrati L
Quad Sclavo Diagn; 1982 Dec; 18(4):454-62. PubMed ID: 7186648
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of malnutrition in uremic patients undergoing hemodialysis therapy in Puglia and Lucania].
Querques M; Strippoli GF; Dell'Aquila R; Gallucci M; Di Iorio B; Manno C;
G Ital Nefrol; 2002; 19(2):160-7. PubMed ID: 12195415
[TBL] [Abstract][Full Text] [Related]
9. Serum alpha-1-acid glycoprotein (orosomucoid) in uremic patients on hemodialysis.
Henriksen HJ; Petersen MU; Pedersen FB
Nephron; 1982; 31(1):24-6. PubMed ID: 7110472
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin levels and malnutrition in patients with chronic renal failure.
Kayardi M; Icagasioglu S; Yilmaz A; Candan F
Saudi Med J; 2006 Apr; 27(4):477-81. PubMed ID: 16598323
[TBL] [Abstract][Full Text] [Related]
11. Serum tumour markers in patients with chronic kidney disease.
Xiaofang Y; Yue Z; Xialian X; Zhibin Y
Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha as a uremic toxin: correlation with neuropathy, left ventricular hypertrophy, anemia, and hypertriglyceridemia in peritoneal dialysis patients.
Espinoza M; Aguilera A; Auxiliadora Bajo M; Codoceo R; Caravaca E; Cirugeda A; del Peso G; Hevia C; Selgas R
Adv Perit Dial; 1999; 15():82-6. PubMed ID: 10682077
[TBL] [Abstract][Full Text] [Related]
13. Hemodialysis reduces the viral load in uremic patients with chronic hepatitis B infection.
Tseng GY; Lin HJ; Fang CT; Cheng YT; Huang CH; Tseng GC; Wang PC; Hung TL; Deng YC; Tsai CC; Yang KY
Ren Fail; 2008; 30(10):1000-5. PubMed ID: 19016152
[TBL] [Abstract][Full Text] [Related]
14. Oxalic Acid as a uremic toxin.
Mydlík M; Derzsiová K
J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
[TBL] [Abstract][Full Text] [Related]
15. Whole blood-, plasma- and red blood cell glutathione and cysteine in patients with kidney disease and during hemodialysis.
Jacobson SH; Moldéus P
Clin Nephrol; 1994 Sep; 42(3):189-92. PubMed ID: 7994938
[TBL] [Abstract][Full Text] [Related]
16. Serum alpha-1-acid glycoprotein levels in uremic patients on hemodialysis.
Docci D; Turci F
Nephron; 1983; 33(1):72. PubMed ID: 6835456
[No Abstract] [Full Text] [Related]
17. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
18. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series.
Basile C; Montanaro A; Masi M; Pati G; De Maio P; Gismondi A
J Nephrol; 2002; 15(6):676-80. PubMed ID: 12495283
[TBL] [Abstract][Full Text] [Related]
19. [Role of hypertension in determining valvular diseases in patients with chronic uremia and dialytic treatment].
Facchin L; Nordio M; Levedianos G; Dilanas C; Marchini P; Leprotti C; Vescovo G
Cardiologia; 1998 Dec; 43(12):1361-6. PubMed ID: 9988945
[TBL] [Abstract][Full Text] [Related]
20. The effects of hemodialysis on duodenal and gastric mucosal changes in uremic patients.
Var C; Gültekin F; Candan F; Türkay C; Sencan M; Içağasioğlu S; Dökmetaş S; Topçu S; Içli F; Var F; Eğilmez R
Clin Nephrol; 1996 May; 45(5):310-4. PubMed ID: 8738662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
